Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 | Zendy

Richard T. Eastman | Zendy; Jacob S. Roth | Zendy; Kyle R. Brimacombe | Zendy; Anton Simeonov | Zendy; Min Shen | Zendy; Samarjit Patnaik | Zendy; Matthew D. Hall | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

Author(s) -

Richard T. Eastman,

Jacob S. Roth,

Kyle R. Brimacombe,

Anton Simeonov,

Min Shen,

Samarjit Patnaik,

Matthew D. Hall

Publication year - 2020

Publication title -

acs central science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.893

H-Index - 76

eISSN - 2374-7951

pISSN - 2374-7943

DOI - 10.1021/acscentsci.0c00489

Subject(s) - covid-19 , pandemic , medicine , clinical trial , virology , viral replication , coronavirus , outbreak , authorization , computational biology , biology , virus , computer science , infectious disease (medical specialty) , computer security , disease , pathology

The global pandemic of SARS-CoV-2, the causative viral pathogen of COVID-19, has driven the biomedical community to action-to uncover and develop antiviral interventions. One potential therapeutic approach currently being evaluated in numerous clinical trials is the agent remdesivir, which has endured a long and winding developmental path. Remdesivir is a nucleotide analogue prodrug that perturbs viral replication, originally evaluated in clinical trials to thwart the Ebola outbreak in 2014. Subsequent evaluation by numerous virology laboratories demonstrated the ability of remdesivir to inhibit coronavirus replication, including SARS-CoV-2. Here, we provide an overview of remdesivir's discovery, mechanism of action, and the current studies exploring its clinical effectiveness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research